TrialJournal of translational medicine2018

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.

Qipeng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.